Income Statement (10X/GENOMICS)

Weiss Ratings reaffirmed their sell (e+) rating on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a report released on Tuesday morning,Weiss Ratings reports. A number of other research analyst… [+5071 chars]...

10x Genomics (NASDAQ:TXG – Get Free Report)‘s stock had its “sell (e+)” rating reissued by analysts at Weiss Ratings in a research report issued to clients and investors on Thursday,Weiss Ratings rep… [+5188 chars]...

Swiss National Bank boosted its holdings in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 1.5% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 188,400 s… [+5657 chars]...

Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) traded down 11.2% during mid-day trading on Thursday after Barclays lowered their price target on the stock from $15.00 to $12.00. Barclays… [+5085 chars]...

Legal & General Group Plc lowered its position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 10.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 101,845 shares … [+5405 chars]...

Barclays PLC lifted its position in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 31.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor … [+5322 chars]...